Nanobiotix (NBTX) Shares Outstanding (Weighted Average) (2018 - 2025)
Nanobiotix (NBTX) recorded quarterly Shares Outstanding (Weighted Average) of $1.7 million in Q4 2025, up 1357313.57% quarter-over-quarter from $124.52 in Q2 2025, and up 11.15% on a YoY basis from $1.5 million in Q4 2024.
Nanobiotix (NBTX) Shares Outstanding (Weighted Average) (2018 - 2025) Analysis & Trends
Nanobiotix's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) rose 11.15% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 11.15% YoY), while the FY2025 annual figure was $1.6 million, up 7.88% from the prior year.
- Shares Outstanding (Weighted Average) was $1.7 million for Q4 2025 at Nanobiotix, up from $124.52 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $39.7 billion in Q4 2023 to a low of $124.52 in Q2 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $4.0 billion across 5 years, with a median of $760835.5 in 2021.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) surged 111564.5% in 2023, then tumbled 100.0% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39.8 million in 2021, then retreated by 10.69% to $35.6 million in 2022, then soared by 111564.5% to $39.7 billion in 2023, then sank by 100.0% to $1.5 million in 2024, then grew by 11.15% to $1.7 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.7 million (Q4 2025), $124.52 (Q2 2025), and $1.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 928.40 Mn |
| 10 | Nanobiotix | 59.17 Mn | -2.23 Mn | - | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.69 Mn |
| Jun 30, 2025 | 124.52 |
| Dec 31, 2024 | 1.52 Mn |
| Jun 30, 2024 | 495.37 |
| Dec 31, 2023 | 39.73 Bn |
| Jun 30, 2023 | 871.14 |
| Dec 31, 2022 | 35.58 Mn |
| Jun 30, 2022 | 810.96 |
| Dec 31, 2021 | 39.84 Mn |
| Jun 30, 2021 | 1,059.76 |
| Dec 31, 2020 | 29.07 Bn |
| Dec 31, 2019 | 24.81 Mn |
| Dec 31, 2018 | 22.41 Mn |